Because of a lapse in government funding, the information on this
website may not be up to date, transactions submitted via the
website may not be processed, and the agency may not be able to
respond to inquiries until appropriations are enacted. The NIH
Clinical Center (the research hospital of NIH) is open. For more
details about its operating status, please visit
cc.nih.gov. Updates
regarding government operating status and resumption of normal
operations can be found at
opm.gov.
Waldenstrom Macroglobulinemia MeSH Descriptor Data 2025
in titles & translations use diacritic: Waldenström
Scope Note
A lymphoproliferative disorder characterized by pleomorphic B-LYMPHOCYTES including PLASMA CELLS, with increased levels of monoclonal serum IMMUNOGLOBULIN M. There is lymphoplasmacytic cells infiltration into bone marrow and often other tissues, also known as lymphoplasmacytic lymphoma. Clinical features include ANEMIA; HEMORRHAGES; and hyperviscosity.
Entry Term(s)
Familial Waldenstrom's Macroglobulinaemia
Lymphoma, Lymphocytic, Plasmacytoid
Lymphoma, Lymphoplasmacytoid
Macroglobulinemia
Primary Macroglobulinemia
Waldenstrom's Macroglobulinaemia
Waldenstrom's Macroglobulinemia
NLM Classification #
WH 540
Public MeSH Note
1999; see WALDENSTROM'S MACROGLOBULINEMIA 1992-98, see MACROGLOBULINEMIA 1963-91; for LYMPHOMA, LYMPHOCYTIC, PLASMACYTOID see LYMPHOMA, SMALL CELL 1991-2007
A lymphoproliferative disorder characterized by pleomorphic B-LYMPHOCYTES including PLASMA CELLS, with increased levels of monoclonal serum IMMUNOGLOBULIN M. There is lymphoplasmacytic cells infiltration into bone marrow and often other tissues, also known as lymphoplasmacytic lymphoma. Clinical features include ANEMIA; HEMORRHAGES; and hyperviscosity.